In Brief: ArthroCare/Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Enter agreement under which Boston Scientific acquires exclusive licensing rights to develop and market ArthroCare's Coblation technology for use in myocardial revascularization. Boston Scientific will pay licensing fees to Sunnyvale, California-based ArthroCare upon achievement of designated clinical and regulatory milestones, and royalties on sales of resulting products. Specific terms of the agreement were not disclosed. ArthroCare began marketing the technology in December 1995 for use in arthroscopic surgery following FDA clearance ("The Gray Sheet" Jan. 26, 1996, p. 22)...